Improving identification of treatment effectiveness in bipolar disorders.
Bowden
Charles L
CL
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D001714:Bipolar Disorder / Q000175:diagnosis* / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000592:standards*; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D005473:Fluoxetine; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine